Security key
702712100
Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)
CUSIP: 702712100
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 3,182,163
- Total 13F shares
- 32,555,495
- Share change
- -1,266,154
- Total reported value
- $13,025,837
- Price per share
- $0.40
- Number of holders
- 36
- Value change
- -$494,591
- Number of buys
- 13
- Number of sells
- 18
Report period
Q2 2025
Institutions
36
Top holders
10
PASG full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Passage BIO, Inc. SEC filings
Passage BIO, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 702712100
Recent filing periods:
Top shareholders of PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Erste Asset Management GmbH |
13F
13D/G
|
Company |
4.4%
from 13D/G
|
2,455,800
|
$868,700 | — | 31 Mar 2025 | |
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · 10%+ Owner |
191%
from 3/4/5
|
7,034,626
|
$2,483,926 | — | 31 Mar 2025 | |
| Lynx1 Capital Management LP |
13F
|
Company |
291%
|
9,256,953
|
$3,268,630 | — | 31 Mar 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
192%
|
6,100,000
|
$2,153,910 | — | 31 Mar 2025 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
78%
|
2,497,922
|
$881,766 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
65%
|
2,071,538
|
$731,252 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
47%
|
1,500,000
|
$529,650 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
44%
|
1,410,276
|
$497,969 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
29%
|
933,764
|
$328,000 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
23%
|
718,450
|
$253,684 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
17%
|
546,101
|
$192,872 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
16%
|
506,142
|
$178,719 | — | 31 Mar 2025 | |
| FIDUCIARY TRUST CO |
13F
|
Company |
6.8%
|
215,000
|
$75,917 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.9%
|
156,773
|
$55,357 | — | 31 Mar 2025 | |
| Shay Capital LLC |
13F
|
Company |
4.6%
|
146,717
|
$51,806 | — | 31 Mar 2025 | |
| RBF Capital, LLC |
13F
|
Company |
4.5%
|
142,807
|
$50,425 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
4.3%
|
136,224
|
$48,101 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
3.5%
|
111,981
|
$39,540 | — | 31 Mar 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
2.6%
|
82,346
|
$29,000 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
2%
|
64,141
|
$22,648 | — | 31 Mar 2025 | |
| DLK Investment Management, LLC |
13F
|
Company |
1.7%
|
53,000
|
$18,714 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.5%
|
46,955
|
$16,580 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
1.4%
|
45,402
|
$16,031 | — | 31 Mar 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.58%
|
18,346
|
$6,478 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.46%
|
14,486
|
$5,114 | — | 31 Mar 2025 | |
| Mariner, LLC |
13F
|
Company |
0.38%
|
11,934
|
$4,214 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.36%
|
11,596
|
$4,095 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.21%
|
6,829
|
$2,411 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.2%
|
6,316
|
$2,230 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.17%
|
5,278
|
$1,864 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.13%
|
4,224
|
$1,491 | — | 31 Mar 2025 | |
| MAI Capital Management |
13F
|
Company |
0.13%
|
4,000
|
$1,413 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.06%
|
2,000
|
$706 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
592
|
$209 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
445
|
$157 | — | 31 Mar 2025 | |
| LRI Investments, LLC |
13F
|
Company |
0.01%
|
225
|
$79 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
186
|
$66 | — | 31 Mar 2025 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
60
|
$21 | — | 31 Mar 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0%
|
50
|
$19 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
47
|
$17 | — | 31 Mar 2025 | |
| Thomas Woiwode |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
24,000
|
— | — | 25 May 2023 | |
| Jill M. Quigley |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
399,988
mixed-class rows
|
$338,849 | — | 08 Dec 2021 | |
| Mark S. Forman |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
261,631
mixed-class rows
|
$56,272 | — | 15 Mar 2024 | |
| Alexandros Fotopoulos |
3/4/5
|
Chief Technical Officer |
—
mixed-class rows
|
53,693
mixed-class rows
|
$48,861 | — | 15 Jun 2023 | |
| Simona King |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
23,994
|
$21,835 | — | 28 Jul 2023 | |
| Monika Maria Toernsen |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
18,319
mixed-class rows
|
$16,670 | — | 15 Sep 2022 | |
| Richard Steven Morris |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
5,454
|
$4,963 | — | 21 May 2021 | |
| Edgar B. Cale |
3/4/5
|
GC & CORPORATE SECRETARY |
—
class O/S missing
|
481,386
|
— | — | 15 Mar 2025 | |
| Saqib Islam |
3/4/5
|
Director |
—
class O/S missing
|
201,857
|
— | — | 28 May 2025 | |
| Eliseo Oreste Salinas |
3/4/5
|
Chief Res. & Develop Officer |
—
class O/S missing
|
157,500
|
— | — | 10 Feb 2022 |
Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q2 2025
As of 30 Jun 2025,
Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,555,495 shares.
The largest 10 holders included
Lynx1 Capital Management LP, Vestal Point Capital, LP, ORBIMED ADVISORS LLC, Erste Asset Management GmbH, VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, BlackRock, Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
40
Q2 2025 holders
36
Holder diff
-4
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.